1-3 of 3
Catherine Guerin
Close
Sort by
Journal Articles

A Genome Wide Association Study Reveals Genetic Predisposition for Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma By Variation in the PREP1-Cbs Locus

Florence Magrangeas, Rowan Kuiper, BSc, Hervé Avet-loiseau, MD PhD, Wilfried Gouraud, Catherine Guérin, Henri Der Sakissian, Jérôme Suhard, Michel Attal, Pieter Sonneveld, MDPhD, Charles Dumontet, MD PhD, Philippe Moreau, Mark van Duin, PhD, Loic Campion, MD, Stephane Minvielle
Journal: Blood
Blood (2014) 124 (21): 2057.
https://doi.org/10.1182/blood.V124.21.2057.2057
Published: 2014
Journal Articles

Low Level Of NF-Kb Activity Is Associated With Higher Response Rate To Bortezomib-Based Induction Therapy In Patients With Newly Diagnosed Multiple Myeloma

Florence Magrangeas, PhD, Philippe Moreau, MD, Loic Campion, MD, Herve Avet-Loiseau, MD, Catherine Guérin, Wilfried Gouraud, Gérald Marit, MD, Michel Attal, MD, Denis Caillot, MD, Thierry Facon, MD, Cyrille Hulin, MD, Lotfi Benboubker, MD, Brigitte Pegourie, MD, Stephane Minvielle, PhD
Journal: Blood
Blood (2013) 122 (21): 3106.
https://doi.org/10.1182/blood.V122.21.3106.3106
Published: 2013
Journal Articles

In Myeloma, the Prognostic Impact of Hyperdiploidy Is Mainly Related to the Gain of Chromosome 5

Herve Avet Loiseau, MD, PhD, Cheng Li, Florence Magrangeas, Catherine Guerin, Wilfried Gouraud, Jean-Luc Harousseau, Michel Attal, MD, Gerald Marit, Claire Mathiot, Thierry Facon, Philippe Moreau, Kenneth C Anderson, MD, Loic Campion, MD, Nikhil C. Munshi, MD, Stephane Minvielle
Journal: Blood
Blood (2008) 112 (11): 632.
https://doi.org/10.1182/blood.V112.11.632.632
Published: 2008